November 17, 2004 Print 
			Friendly Format
2005 Annual Update for Clinical Laboratory Fee Schedule

CMS
Publication Date: November 05, 2004
Effective Date: January 01, 2005

Internet access to the 2005 clinical laboratory fee schedule data file will be available after November 18, 2004, at:  Payment Systems. Medicaid State agencies, the Indian Health Service, the United Mine Workers, Railroad Retirement Board, and other interested parties should use the Internet to retrieve the 2005 clinical laboratory fee schedule. It will be available in multiple formats: Excel, text and comma delimited.

Pricing Information for the Travel Fee
For dates of service January 01, 2005 through December 31, 2005, the standard mileage rate for transportation costs is $0.385. The 2005 payment for code P9603 is $.835 and for code P9604 is $8.35.

For 2005, the clinical laboratory fee schedule will not include code G0001 and will include code 36415 Collection of venous blood by venipuncture. Code 36415 was released as not payable by Medicare in the 2005 HCPCS update file. However, code 36415 has now been activated to be payable by Medicare effective January 01, 2005. CPT code 36416 relating to a capillary specimen collection remains not payable by Medicare as a separate service.

Mapping Information for New and Revised Codes

  • New code 82045 is priced at the same rate as code 83880.
  • New code 82656 is priced at the same rate as code 83516.
  • New code 83009 is priced at the same rate as code 83013.
  • New code 83630 is priced at the same rate as code 83516.
  • New code 84163 is priced at the same rate as code 84702.
  • New code 84166 is priced at the sum of the rates of codes 84165 and 87015.
  • New code 84450QW is priced at the same rate as code 84450.
  • New code 86064 is priced at the same rate as code 86359.
  • New code 86335 is priced at the sum of the rates of codes 86334 and 87015.
  • New code 86379 is priced at the same rate as code 86359.
  • New code 86587 is priced at the same rate as code 86359.
  • New code 87807 is priced at the same rate as code 87804.

Reference: Medicare Transmittal 363  CR 3526.




Beneficiary Signature Requirements

CMS

Beneficiary signatures are required on submitted claims in item 12 of the CMS-1500 claim form.

In lieu of signing the claim, the patient may sign a statement or authorization form to be retained in the provider's file indefinitely, unless revoked by the patient. The provider can then submit "signature on file" in item 12.

For electronic claims submitted in ANSI 4010A1 format, submitters/providers must enter one of the following values in Loop 2300 2-130- CLM10:

    B - Signed signature authorization form or forms for both CMS-1500 Claim Form item 12 and item 13 are on file

    C - Signed CMS-1500 Claim Form on file

    M - Signed signature authorization form for CMS-1500 Claim Form item 13 on file

    P - Signature generated by provider because the patient was not physically present for services

    S - Signed signature authorization form for CMS-1500 Claim Form item 12 on file

For more information on signature requirements, refer to Claim Form CMS-1500  Instructions.




CCI Quarterly Update

CMS
Publication Date: October 22, 2004
Effective Date: January 01, 2005

The latest package of Correct Coding Initiative (CCI) edits, Version 11.0, effective January 01, 2005, will be available via the CMS Data Center (CDC). A test file will be available on or about November 01, 2004, and the final file will be available on or about November 16, 2004.

Version 11.0 will include all previous versions and updates from January 01, 1996, to the present and will be organized in two tables: Column 1/ Column 2 Correct Coding Edits and Mutually Exclusive Code (MEC) Edits.

Reference: Medicare Transmittal 324  CR 3491.




New CLIA Waived Tests

CMS
Publication Date: September 30, 2004
Effective Date: October 01, 2004

 

The Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations require a facility to be appropriately certified for each test performed. To ensure that Medicare and Medicaid only pay for laboratory tests categorized as waived complexity under CLIA in facilities with a CLIA certificate of waiver, laboratory claims are currently edited at the CLIA certificate level.

Listed below are the latest tests, effective October 01, 2004.

 
CPT
Code/Modifier
Effective
Date
Description   
   86318QW    3-23-2004    Acon® H. pylori Test Device
   82010QW,
   82962
   4-15-2004    Abbott Medisense Precision Xtra Advanced Diabetes Management System (K040814)
   85018QW    5-4-2004    HemoCue Hemoglobin 201+/HemoCue Hemoglobin Microcuvette System
   83001QW    5-11-2004    Synova Healthcare MenocheckPro (Professional Use)
   82274QW,
   G0328QW
   5-26-2004    Beckman Coulter Hemoccult ICT
 

Reference: Medicare Transmittal 258  CR 3372.

 

 

Publication Date: October 22, 2004
Effective Date: January 01, 2005

 
CPT Code/
Modifier
Effective Date Description
   87804QW    2-6-2004 Quidel Quickvue Influenza A+B Test
   87880QW    4-15-2004 DE Healthcare Products TruView Strep A Cassette Test
   87880QW    6-4-2004 Polymedco Poly Stat Strep A Liquid Test
   84450QW    6-18-2004 Cholestech LDX (Whole Blood)
   87880QW    6-28-2004 Immunostics Detector Strep A Direct
   83001QW    6-28-2004 Acon Laboratories, Inc. FSH Menopause Predictor Test
   85018QW    6-30-2004 HemoCue Hemoglobin 201+ (Capillary, Venous, Arterial Whole Blood)
   82465QW,
   83718 QW,
   84478 QW,
   80061QW
   7-9-2004 Piccolo Point of Care Chemistry Analyzer (Lipid Panel Reagent Disc) (Whole Blood)
   87880QW    7-15-2004 Genzyme OSOM Ultra Strep A Test
   80101QW    8-24-2004 Accu-Stat Drugs of Abuse Home Test for Marijuana (THC) and Cocaine (COC)
   80101QW    8-24-2004 Accu-Stat Drugs of Abuse Home Test for Marijuana (THC)
 

CLIA has approved new waived code, 84450QW, for the aspartate aminotransferase (AST) test performed on the Cholestech LDX (Whole Blood) test system effective January 03, 2005.

 

Reference: Medicare Transmittal 325  CR 3484.




ESRD Reimbursement for AutoChems

CMS
Publication Date: October 04, 2004
Effective Date: January 01, 2005

All chemistries ordered for ESRD patients must be billed individually with the following modifiers:

    CD - AMCC test that has been ordered by an ESRD facility that is part of the composite rate

    CE - AMCC test that has been ordered by an ESRD facility that is a composite rate test, but is beyond the normal frequency covered under the rate and is separately reimbursable based on medical necessity

    CF - AMCC test that is not part of the composite rate and is a separately billable test that has been ordered by an ESRD facility

Medicare will calculate the number of AMCC services provided for any given date of service and divide the number of services with a CD modifier by the total number of services. If the calculation is 50% or greater, the carrier will not pay for the test. If the result is less than 50%, the carrier will pay for all the services.

For further detail refer to:  Transmittal 198  CR 2813.




Remittance Advice Remark Code and Claims Adjustment Reason Code Update

CMS
Publication Date: August 01, 2004
Effective Date: January 01, 2005

The Remittance Advice Remark Codes are maintained by CMS and updated three times per year. The June 2004 updates for the X12N 835 Health Care Remittance Advice Remark Codes and the X12N835 Health Care Claim Adjustment have been posted and are available on line at: http://www.wpc-edi.com/codes/Codes.asp

The new codes will become effective on January 01, 2005. The following codes have been added: 
  

Code Description          
   N217       We pay only one site of service per provider per claim
   N218      You must furnish and service this item for as long as the patient continues to need it. We can pay for maintenance and/or servicing for the time period specified in the contract or coverage manual.
   N219      Payment based on previous payer's allowed amount.
   N220      See the payer's web site or contact the payer's Customer Service department to obtain forms and instructions for filing a provider dispute.
   N221      Missing Admitting History and Physical report.
   N222      Incomplete/invalid Admitting History and Physical report.
   N223      Missing documentation of benefit to the patient during initial treatment period.
   N224      Incomplete/invalid documentation of benefit to the patient during initial treatment period.
   N225      Incomplete/invalid documentation/orders/ notes/ summary/ report/ invoice.
   N226      Incomplete/invalid American Diabetes Association Certificate of Recognition.
   N227      Incomplete/invalid Certificate of Medical Necessity.
   N228      Incomplete/invalid consent form.
   N229      Incomplete/invalid contract indicator.
   N230      Incomplete/invalid indication of whether the patient owns the equipment that requires the part or supply.
   N231      Incomplete/invalid invoice or statement certifying the actual cost of the lens, less discounts, and/or the type of intraocular lens used.
   N232      Incomplete/invalid itemized bill.
   N233      Incomplete/invalid operative report.
   N234      Incomplete/invalid oxygen certification/re-certification.
   N235      Incomplete/invalid pacemaker registration form.
   N236      Incomplete/invalid pathology report.
   N237      Incomplete/invalid patient medical record for this service.
   N238      Incomplete/invalid physician certified plan of care
   N239      Incomplete/invalid physician financial relationship form.
   N240      Incomplete/invalid radiology report.
   N241      Incomplete/invalid Review Organization Approval.
   N242      Incomplete/invalid x-ray.
   N243      Incomplete/invalid/not approved screening document.
   N244      Incomplete/invalid pre-operative photos/visual field results.
   N245      Incomplete/invalid plan information for other insurance
   N3      Missing consent form.
   MA92      Missing plan information for other insurance.
   M29      Missing operative report.
   M30      Missing pathology report.
   M31      Missing radiology report.
   

Reference:   Code Lists.




Temporary Change in Carrier Jurisdictional Pricing Rules for Purchased Diagnostic Services

CMS
Publication Date: October 22, 2004
Effective Date: November 22, 2004

This temporary change requires placing the referring labs' address in field 32 on the HCFA and in loop 2010AA on the electronic format.

Until further notice, physicians/suppliers must bill their local carrier for all purchased diagnostic tests/interpretations, regardless of the location where the service was furnished. The billing physician/ supplier is responsible for ensuring that the physician/ supplier that furnished the purchased test/interpretation is enrolled with Medicare, and is in good standing (i.e., the physician/supplier is not sanctioned, barred, or otherwise excluded from participating in the Medicare program). The billing physician/supplier is also responsible for any existing billing arrangements between the purchasing entity and the entity providing the service.

When billing for an out-of-jurisdiction purchased diagnostic service, the physician/supplier must report the address of its own facility in the service facility location area of the claim. (For these services only, the place of service is deemed to be the billing physician/ supplier’s location, rather than the location where the service was actually performed. The billing physician/supplier should use the same address reported for the portion of the service that the physician/supplier performed when reporting the address for the purchased portion of the test.) Physicians/suppliers billing for the purchased test/interpretation must enter the address of their facility in block 32 of the Form CMS-1500 claim form. For electronic claims submissions, physicians/suppliers billing for the purchased test/ interpretation must enter the address of their facility in the Billing Provider loop 2010AA of the ANSI X12 837 electronic claim format, version 4010/4010A. See IOM Publication 100-04, Medicare Claims Processing Manual, chapter 1, §10.1.1.1 for further guidance concerning the submission of electronic claims.

Reference: Transmittal 315  CR 3464.




Claim Corrections

NHIC – California and New England
Publication Date: November 04, 2004

NHIC often receives requests to correct a claim as a result of a billing error.

Claim corrections are generally simple corrections. For example:

  • Dates of service entered incorrectly (i.e., 09152003 instead of 09152004)
  • Units entered as 0001 instead of 0010
  • Dollars entered as 2.00 instead of 200.00

To request corrections as a result of these issues, providers may do one of two things:

  • Submit the remittance advices with the claim(s) in question identified, along with a reason for the correction.
  • Submit a list that contains the beneficiary name, HIC number, ICN, date of service, along with a request to correct the item billed or paid incorrectly and the reason for the change.

Requests for corrections should be sent to the appropriate post office box.

  • For Northern California: Medicare Written Inquiries, PO Box 2006, Chico, CA 95927-2006.
  • For Southern California: Medicare Adjustments, PO Box 272857, Chico, CA 95927-2857.
  • For New England: Medicare Written Inquiries, P.O. Box 1000; Hingham, MA 02044.

Reference:  NHIC.




LMRP Updates

California - NHIC

  • Amylase
    Publication Date: September 22, 2004
    Effective Date: October 01, 2004

    The LMRP for Amylase (CPT code 82150) has been updated to include the following change:

    • Deleted information in the Non-covered ICD-9 Codes section due to duplicative information.

    Reference: NHIC Policy  03-02.1R2.

 

 
  • Cytogenetic Studies
    Publication Date: October 09, 2004
    Effective Date: October 01, 2004

    The LMRP for Cytogenetic Studies (88230, 88233, 88235, 88237, 88240, 88241, 88245, 88248, 88249, 88261, 88262, 88263, 88264, 88267, 88269, 88271, 88272, 88273, 88274, 88275, 88280, 88283, 88285, 88289, 88291, 88299) have been updated to include the following 2005 ICD-9-CM changes:

    • Deleted 758.3
    • Added 758.31, 758.32, 758.33 and 758.39;
    • Deleted information in the Non-covered ICD-9 Codes section due to duplicative information.

    Reference: NHIC Policy  03-02.3R3.

 

 
  • Flow Cytometry
    Publication Date: October 14, 2004
    Effective Date: January 01, 2004

    The LMRP for Flow Cytometry (88180, 88342) has been updated to include the following changes:

    • Corrected truncated ICD-9-CM code 236.9 to 236.90

    • Corrected truncated ICD-9-CM code 203.0 to 203.00

    Reference: NHIC Policy  02-06.1R2.

 

 
  • FSH and LH
    Publication Date: October 28, 2004
    Effective Date: October 01, 2004

    The LMRP for Follicle stimulating hormone (FSH) and luteinizing hormone (LH) (88301, 83002) has been updated to include the following changes:

    • Removed language from the Indications and Limitations section and in the National Policy Section.
    • This LCD was converted from an LMRP on 10/28/2004.

    Reference: NHIC Policy  03-02.6R3.

 

 
  • Hepatitis C Virus Molecular Tests
    Publication Date: October 12, 2004
    Effective Date: October 01, 2004

    The LMRP for Hepatitis C Virus Molecular Tests (CPT codes 87520, 87521, 87522, 87902, 87999) have been updated to include the following 2005 ICD-9-CM changes:

    • Added ICD-9 codes 070.70, 070.71 (070.41, 070.51 title changes)

    Reference: NHIC Policy  01-04.02R5.




Making Voluntary Refunds to Medicare

California - NHIC
Publication Date: November 20, 2004

If you discover that an overpayment of Medicare funds has occurred, you are expected to notify the program and take appropriate actions to remedy the situation.

Please complete and forward the appropriate information to NHIC, your Medicare contractor. The attached form is required, or a similar document containing the following information, to accompany every unsolicited/voluntary refund so that receipt of check is properly recorded and applied. If specific patient/HIC/Claim # information is not provided, no appeal rights can be afforded with respect to the refund. Providers/physicians/suppliers, and other entities who are submitting a refund under the OIG’s Self-Disclosure Protocol or who are under a CIA, are not afforded appeal rights as stated in the signed agreement presented by the OIG.

National Heritage Insurance Company (NHIC) would like to emphasize the importance of submitting voluntary refunds with proper information to ensure that the refund is processed accurately and on a timely basis. All funds returned to the program should include relevant information to properly account for the refund.

  • Fill out the "Overpayment Refund Form" completely for each claim, (if available, submit a copy of the Remittance Advice (RA) or Medicare Summary Notice (MSN) with the claim highlighted and notated with the exact amount of the refund and the reason for the refund), or
  • Submit a spread sheet listing the following information for each claim:
    • Claim Internal Control Number (ICN) from the Medicare RA/MSN
    • Patient HIC Number from the Medicare RA/MSN
    • Patient’s Name as shown exactly on the Medicare RA/MSN
    • Date of Service
    • Procedure Code
    • Refund Reason
    • Refund Amount
    • For OIG Reporting Requirements:

    Do you have a Corporate Integrity Agreement with OIG? ____ Yes ____No

    Are you a participant in the OIG Self-Disclosure Protocol? ____ Yes ____ No

In addition:

  • Be sure to use the claim identifying information from the Medicare RA/MSN that you received. Do not use your own internal account numbers, patient numbers, or invoice dates, etc.
  • Make checks payable to: Medicare
  • Submit Medicare Secondary Payer (MSP) refunds to:
    • For New England: Medicare Cash Accounting, P.O. Box 9103, Hingham, MA 02044
    • For Northern California: Medicare Secondary Payer Refunds, P.O. Box 951, Marysville, CA 95901
    • For Southern California: Medicare Cash Accounting, P.O. Box 515301, Los Angeles, CA 90051-6601
  • Submit all other refunds to:
    • For New England: Medicare Cash Accounting, P.O. Box 9103, Hingham, MA 02044
    • For Northern California: Medicare Cash Accounting, P.O. Box 391, Marysville CA 95901
    • For Southern California: Medicare Cash Accounting, P.O. Box 515301, Los Angeles, CA 90051-6601

Reference:   Voluntary Refunds  NHIC.




Screening for Data

California - NHIC
Publication Date: September 23, 2004
Effective Date: December 01, 2004

A reminder to all providers that item 11 must be completed on the CMS-1500 claim form. Although this information has been required by CMS, NHIC has not been screening for it. Effective December 01, 2004, NHIC will begin to audit the paper claim form for this information, and if it is missing, your claim will be rejected.

Reference:   Info for Providers  Medicaid Update.




New Address For Paper and Adjusted Claims

California – United Government Services Medicare Fiscal Intermediary
Publication Date: November 01, 2004
Effective Date: December 01, 2004

Effective December 01, 2004, the new PO Box number for submission of paper claims and adjustments from all California workload providers is PO Box 3161.

This change completes the UGS objective of having all paper claims and adjustments received in a single location to provide better control efficiency and operations effectiveness.

Depending on your service area, the correct UGS PO Box for paper claim and adjustment submission is as follows:

  • California (Service Area 6,7,8) PO Box 3161 - Milwaukee, WI 53201-3161
  • Wisconsin (Service Area 3,4,5) PO Box 2119 - Milwaukee, WI 53201-2019
  • Michigan (Service Area 2) PO Box 3112 - Milwaukee, WI 53201-3112
  • Virginia (Service Area 1) PO Box 3234 - Milwaukee, WI 53201-3234

California provider paper claims and adjustments received in PO Box 9140, Oxnard, California, after December 01, 2004 could experience a delay in processing. The new address for paper claims and adjustments from California workload providers is PO Box 3161

Reference: UGS  New PO Box.




LMRP Updates
California – United Government Services
 
  • Serum Magnesium
    Publication Date: October 01, 2004
    Effective Date: October 01, 2004

    The LMRP for Serum Magnesium (83735) has been revised.

    • Added 5th digit to ICD-9 codes 252.00 - 252.9 Disorders of parathyroid gland
    • Added 588.9, 588.81 and V58.66
    • Deleted 588.8
    • Revised 070.70, 070.71, 291.0, 291.1, 291.2, 291.3, 292.0, 293.0, 294.8, 294.9, 307.22, 307.51 and 760.71

    Reference: UGS Policy  U01.19.01.




2004 CPT-4, HCPCS Additional Policy Changes

California - Medi-cal
Publication Date: October 2004
Effective Date: October 18, 2004

The 2004 updates to the Current Procedural Terminology – 4th Edition (CPT-4) and Healthcare Common Procedure Coding System (HCPCS) National Level II and Local Level III codes are effective for Medi-Cal for dates of service on or after October 18, 2004 and policies were published in the September Medi-Cal Update. Additional policy changes are highlighted below.

Radiology
Codes Requiring Split Bill Modifiers
HCPCS radiopharmaceutical codes A9525 and A9528 – A9532 are 100 percent professional and must be billed with modifiers -26 or -ZS. The codes are billable by hospitals or radiologists.

Maximum Reimbursement: Code Combinations
Only one code in the combination of CPT-4 codes 70250 v. 70260 will be reimbursed if billed for the same date of service, same provider.

 

Reference: Medi-Cal Publication, General Medicine,  Bulletin 363.

 

 

Prenatal Cystic Fibrosis Screening
Publication Date: October 2004
Effective Date: November 01, 2004

Effective for dates of service on or after November 01, 2004, providers may bill for up to a maximum quantity of 25 combination laboratory tests listed below, which screen for the presence of a mutant gene likely to contribute to a pregnant woman giving birth to a baby with cystic fibrosis. 
  

CPT-4
Code
Description          
83890   Molecular diagnostics; molecular isolation or extraction
83891     isolation or extraction of highly purified nucleic acid
83892     enzymatic digestion
83893     dot/slot blot production
83894     separation by gel electrophoresis
    (e.g. agarose, polyacrylamide)
83896     nucleic acid probe, each
83897     nucleic acid transfer (e.g. Southern, Northern)
83898     amplification of patient nucleic acid (e.g. PCR, LCR),
    single primer pair, each primer pair
83901     amplification of patient nucleic acid, multiplex,
    and each multiplex reaction
83904     mutation identification by sequencing, single segment,
    each segment
 

Note: CPT-4 code 83912 (interpretation and report) is still limited to one per day.

 

In addition, the following conditions apply:

  • Providers must document in the diagnosis field of the claim ICD-9 diagnosis code V26.3 genetic counseling and testing.
  • Fetal testing is reimbursable using the recipient's Medi-Cal identification number if "fetal specimen" and medical justification is documented in the Remarks area/Reserve For Local Use field (Box 19). Failure to document these tests will result in denial of the claim.
  • Cystic fibrosis screening is reimbursable for the father only if he is a Medi-Cal recipient. Providers must document in the Remarks area/Reserved For Local Use field (Box 19), "patient screen positive/partner sample his recipient number" and ICD-9 code V26.3 or the claim will be denied.
  • Cystic fibrosis screening is an once-in-a-lifetime procedure.
  • The maximum reimbursement for any combination of the above codes is $180.

The updated information is reflected on manual replacement pages path molec 1 and 2. (Part 2).

 

Reference: Medi-Cal Publication, General Medicine,  Bulletin 363.




New Benefits Identification Cards

California - Medi-Cal
Effective Date: January 2005

Beginning January 2005, Medi-Cal will be issuing new Benefits Identification Cards (BIC) with a 14-character BIC ID. A statewide phase-in process will be used to issue cards to all Medi-Cal recipients. The Department of Health Services' goal is to replace all 10-character BIC IDs by July 01, 2005.

You can see a facsimile of the letter:  EDS letter.




New Medi–Cal Benefit: Chest Ultrasound

California – Medi-Cal
Publication Date: November 2004

Effective for dates of service on or after December 1, 2004, CPT-4 code 76604 (ultrasound, chest, B-scan [includes mediastinum] and/or real time with image documentation) is a Medi-Cal benefit. This practice is limited to four claims per year, for the same recipient, by any provider. Additional claims for this code must be accompanied with appropriate medical justification.The updated information is reflected on manual replacement pages radi 8 (Part 2) and tar and non cd7 2 (Part 2).

Medi-Cal Update:  Bulletin 364.




New Ultrasound Benefit

California – Medi-Cal
Publication Date: November 2004

Effective for dates of service on or after December 1, 2004, CPT-4 code 76800 (ultrasound, spinal canal and contents) is a Medi-Cal benefit. Code 76800 is reimbursable for recipients 5 years of age or younger, for up to two procedures per calendar year for the same recipient, any provider. Additionally, code 76800 is reimbursable only when billed in conjunction with one of the following ICD-9 diagnosis codes, which must be documented in the Primary ICD-9-CM field (Box 21):
  

ICD-9
Code
Description          
 324.1 Intraspinal abscess.
 685.1 Pilondial cyst; without mention of abscess.
 741.9 Spina bifida; without mention of hydrocephalus.
 741.93    lumbar region
 751.2 Atresia and stenosis of large intestine, rectum, and anal canal.
 756.13 Anomalies of spine; absence of vertebra, congenital.
 

Reimbursement for additional procedures (more than two per calendar year) requires a Treatment Authorization Request (TAR) with medical justification.

 

The updated information is reflected on manual replacement pages radi ult 2 (Part 2) and tar and non cd7 2 (Part 2).

 

Reference:  Medi-Cal Update Bulletin 364.




Positron Emission Tomography Scan Benefit Update

California – Medi-Cal
Publication Date: November 2004

Effective for dates of service on or after December 1, 2004, reimbursement guidelines for Positron Emission Tomography (PET) scans when billed with CPT-4 code 78810 (tumor imaging, positron emission tomography [PET], metabolic evaluation) will be expanded to include the restaging of recurrence of residual thyroid cancers of follicular cell origin that have been previously treated by thyroidectomy and radioiodine ablation for recipients with a serum thyroglobulin level greater than 10 mg/ml and a negative 1-131 whole body scan.

Reminder: Reimbursement for CPT-4 code 78810 requires a Treatment Authorization Request (TAR) for medical documentation or the claim will be denied.

The updated information is reflected on manual replacement page radi nuc 2 (Part 2).

Medi-Cal Update:  Bulletin 364.




WPS 2005 Fee Schedule Correction

Medicare:  Illinois – Wisconsin Physician Services

Listserv Notification: November 11, 2004

Wisconsin Physician Service (WPS) 2005 Fee Schedule contained incorrect pricing due to a miscalculation.

The fees were miscalculated, and WPS was unable to include the correct fees on the CD-ROM. The WPS Web site will be updated with the most current fees as soon as the revised fees are available.

The revised fees and the CD-ROM will be available from:  WPS 2005 Fee Schedule Information.




LMRP Updates

Medicare:  New York – Empire

 
  • Collagen Crosslinks, any method
    Publication Date: October 01, 2004
    Effective Date: October 01, 2004

    The LMRP for Collagen Crosslinks has been updated to include the following changes:

    • Added codes 252.00-252.02 and 252.08 to the "ICD-9-CM Codes that Support Medical Necessity" section of the LCD.

    Reference: Empire Policy  LB009E02.

 

 
  • Flow Cytometry

    Publication Date: October 08, 2004
    Effective Date: November 08, 2004

    The LMRP for Flow Cytometry (88180, 88182) has been updated to include the following changes:

    • Added ICD-9-CM codes 153.0-153.9, 154.0-154.8, 238.7, 273.1, 273.3, 277.3, 283.2, 284.8, 284.9, 288.8, V08, V42.9 and V71.1

    Reference: Empire Policy   YPATH33R1.

 

 
  • Lipid Profile
    Publication Date: October 01, 2004
    Effective Date: October 01, 2004

    The LMRP for Lipid Profiles (80061, 82172, 82465, 83715, 83716, 83718, 83719, 83721 and 84478) have been updated to include the following 2005 ICD-9-CM changes:

    • Added codes 588.81 and 588.89 to the "ICD-9-CM codes that Support Medical Necessity" section of the LCD
    • Removed ICD-9-CM code 588.8, as it is no longer valid.

    Reference: Empire Policy  LB007E07.

 

 
  • Prostate Specific Antigen (PSA)
    Publication Date: October 01, 2004
    Effective Date: October 01, 2004

    The LMRP for Prostate Specific Antigen (PSA) (G0103, 84152, 84153 and 84154) have been updated to include the following 2005 ICD-9-CM changes:

    • Added code 600.01 to the "ICD-9-CM Codes that Support Medical Necessity" section of the LCD.

    Reference: Empire Policy  LB012E02.

 

 
  • Serum Magnesium
    Publication Date: October 01, 2004
    Effective Date: October 01, 2004

    The LMRP for Serum Magnesium (83735) has been revised.

    • Added 070.41, 070.51, 070.70, 070.71, 250.00-250.93, 252.01, 588.81 and 588.89.
    • As a result of coordination between New York and New Jersey, the ICD-9-CM code list has been expanded, additional indications and documentation requirements have been added for NY.

    Reference: Empire Policy  YPTH#15r2.

 

 
  • Viral Hepatitis Serology Tests
    Publication Date: October 01, 2004
    Effective Date: October 01, 2004

    The LMRP for Viral Hepatitis Serology Tests (86704, 86705, 86706, 86707, 86708, 86709, 86803, 86804, 87340, 87341, 87350 and 87380) have been updated to include the following 2005 ICD-9-CM changes:

    • Added 070.70 and 070.71, to the "ICD-9-CM Codes that Support Medical Necessity" section of the LCD.

    • Added 7V01.79 has been added to the "ICD-9-CM Codes that Support Medical Necessity" section of the LCD.

    Reference: Empire Policy  LB013E03.


 

Return to Top

Contact Us | Privacy Statement | Legal
© 2004 XIFIN®, Inc. All rights reserved.